Drug Profile
PD 165557
Latest Information Update: 23 Jul 2002
Price :
$50
*
At a glance
- Originator Nonindustrial source; Pfizer
- Class Antineoplastics
- Mechanism of Action Epidermal growth factor receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 21 Jun 2000 Warner-Lambert has merged with Pfizer
- 29 Jul 1999 New profile
- 29 Jul 1999 Preclinical development for Cancer in New Zealand (Unknown route)